| 000 | 01593 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250516054347.0 | ||
| 264 | 0 | _c20120214 | |
| 008 | 201202s 0 0 eng d | ||
| 022 | _a1528-0020 | ||
| 024 | 7 |
_a10.1182/blood-2011-08-335612 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLopes, Renato D | |
| 245 | 0 | 0 |
_aWarfarin and acetaminophen interaction: a summary of the evidence and biologic plausibility. _h[electronic resource] |
| 260 |
_bBlood _cDec 2011 |
||
| 300 |
_a6269-73 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAcetaminophen _xadministration & dosage |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAnalgesics, Non-Narcotic _xadministration & dosage |
| 650 | 0 | 4 |
_aAnticoagulants _xadverse effects |
| 650 | 0 | 4 |
_aAtrial Fibrillation _xcomplications |
| 650 | 0 | 4 |
_aBack Pain _xblood |
| 650 | 0 | 4 |
_aBiotransformation _xdrug effects |
| 650 | 0 | 4 |
_aDiabetes Complications _xphysiopathology |
| 650 | 0 | 4 | _aDrug Interactions |
| 650 | 0 | 4 | _aDrug Monitoring |
| 650 | 0 | 4 |
_aEmbolism _xetiology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypertension _xcomplications |
| 650 | 0 | 4 | _aInternational Normalized Ratio |
| 650 | 0 | 4 |
_aVitamin K _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aWarfarin _xadverse effects |
| 700 | 1 | _aHorowitz, John D | |
| 700 | 1 | _aGarcia, David A | |
| 700 | 1 | _aCrowther, Mark A | |
| 700 | 1 | _aHylek, Elaine M | |
| 773 | 0 |
_tBlood _gvol. 118 _gno. 24 _gp. 6269-73 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1182/blood-2011-08-335612 _zAvailable from publisher's website |
| 999 |
_c21151607 _d21151607 |
||